Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The efficacy and safety of nine South African medicinal plants in controlling Bacillus anthracis Sterne vaccine strain

  • Ishaku Leo Elisha1, 2,
  • Jean-Paul Dzoyem1, 3,
  • Francien S. Botha1 and
  • Jacobus Nicolaas Eloff1Email author
BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201616:5

https://doi.org/10.1186/s12906-015-0980-1

Received: 12 July 2015

Accepted: 23 December 2015

Published: 8 January 2016

Abstract

Background

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive spore-forming bacterium. The presence of the bacteria and the toxins in the blood of infected hosts trigger a cascade of pathological events leading to death. Nine medicinal plants with good activities against other bacteria were selected to determine their in vitro antibacterial activity against Bacillus anthracis Sterne strain. The cytotoxicity of the extracts on Vero kidney cells was also determined.

Results

The minimum inhibitory concentration (MIC) values of the extracts against Bacillus anthracis Sterne strain ranged from 0.02 to 0.31 mg/ml. Excellent MIC values were observed for the following plant species: Maesa lanceolata (0.02 mg/ml), Bolusanthus speciosus, Hypericum roeperianum, Morus mesozygia (0.04 mg/ml) and Pittosporum viridiflorum (0.08 mg/ml). The total antibacterial activity of the extracts ranged from 92 to 5562 ml/g. Total activity presents the volume to which the extract from 1 g of plant material can be diluted and still inhibit microbial growth. Maesa lanceolata and Hypericum roeperianum had the highest total activity with values of 5562 and 2999 ml/g respectively. The extracts of Calpurnia aurea had the lowest total activity (92 ml/g). The cytotoxicity determined on Vero cells indicated that most of the extracts were relatively non-toxic compared to doxorubicin (LC50 8.3 ± 1.76 μg/ml), except for the extracts of Maesa lanceolata, Elaeodendron croceum and Calpurnia aurea with LC50 values at 2.38 ± 0.25, 5.20 ± 0.24 and 13 ± 2.26 μg/ml respectively. The selectivity index (SI) ranged from 0.02 to 1.66. Hypericum roeperianum had the best selectivity index, (SI = 1.66) and Elaeodendron croceum had lowest value (SI = 0.02).

Conclusions

The crude acetone extracts of the selected plant species had promising antibacterial activity against Bacillus anthracis. Maesa lanceolata extracts could be useful as a disinfectant and Hypericum roeperianum could be useful to protect animals based on its high total activity and selectivity index. Further investigation of these plant extracts may lead to the development of new therapeutic agents to protect humans or animals against anthrax.

Keywords

Bacillus anthracis Medicinal plants Antibacterial activity Total activity Cytotoxicity Selectivity index

Background

Anthrax is a serious zoonotic disease of great economic and social importance [1]. It is caused by Bacillus anthracis, a Gram-positive spore-forming bacterium [2]. The disease can affect most mammals and several species of birds, but is particularly important in herbivores, such as cattle, sheep and goats [1, 2]. Humans contract anthrax by handling infected animals or products of animals that have died from the disease [3]. Once infection sets in, spores germinate into capsulated bacilli capable of producing toxins. The presence of the bacteria and their toxins in the blood of the infected host triggers a cascade of pathological events leading to death [3]. B. anthracis has always been high on the list of agents that could be used in biological warfare and bioterrorism [4]. The disease is still endemic in many countries of Africa and Asia [3].

The major virulence factors of B.anthracis are encoded on two virulence plasmids pXO1 and pXO2 [5]. The tri-toxin bearing plasmid pXO1 codes for three toxins, which cause haemorrhage, oedema, and necrosis [6]. They comprise the lethal factor, oedema factor, and the protective antigen, in the host cell receptor component. The exotoxins are binary, with the protective antigen acting as the binding domain that allows entry of the toxin into the host cell. The smaller capsule bearing plasmid pXO2 encodes three genes (cap B, cap C, and cap A) involved in the synthesis of the poly-D- glutamyl capsule that inhibits host phagocytosis of the vegetative form of B. anthracis. Both plasmids are necessary for full virulence; loss of either results in an attenuated strain. Sterne B. anthracis strain, carries pXO1 and therefore can synthesise exotoxin, but does not have a capsule [5]. Microbiology laboratories use B. anthracis Sterne strain for accurate identification and diagnosis of anthrax, and occasionally for anthrax research [7].

B. anthracis spores have the capacity to contaminate a given area for a long time, because of their intrinsic ability to survive different environmental conditions and chemical disinfectants [2, 8]. Anthrax spores have been isolated after 60 years from contaminated sites [8, 9]. B. anthracis has been recovered from animal bones estimated to be over 200 years old in the Kruger National Park in South Africa [10].

Control measures employed during anthrax outbreaks include vaccination of livestock using the avirulent B. anthracis Sterne strain [7], burial or burning of dead animals and calcium oxide (lime) application on burial sites [2, 11]. Anthrax infections can be treated effectively with antibiotics, provided treatment is started early. Penicillin has been the antibiotic of choice for many years [1]. Where the use of penicillin is contraindicated or ineffective, ciprofloxacin and doxycycline are good alternatives [4]. B. anthracis natural or acquired resistance to broad spectrum antibiotics [1214], as well as poor penetration of doxycycline into the central nervous system of infected individuals, necessitate the search for new antimicrobials that could offer effective and potent alternatives in face of bioterrorist attack or anthrax epidemics [4].

Plants have always played a central part in combating ailments in humans and livestock in many indigenous communities [15]. Herbal extracts or decoctions from different plant parts have been used in both ethnoveterinary and ethnomedicinal practices to treat anthrax in animals and humans [1619]. Traditional use of the following plants have been documented in the treatment of anthrax in livestock and humans, Senna italica, Teucrium africanum, Ptaeroxylon obliquum, Achyrospermum schimperi, Teucrium polium [16, 17, 20].

The Phytomedicine Programme, University of Pretoria, has screened over 700 acetone leaf extracts of more than 530 tree species for their antimicrobial properties beneficial to man and animals [21]. Nine plant species with high antibacterial activities were selected from the database and tested against Bacillus anthracis Sterne strain. The cytotoxicity was also determined using the MTT assay against Vero kidney cells.

Methods

Collection of plant material

The leaves of Heteromorpha arborescens (Spreng.) Chan. & Schltdl, Bolusanthus speciosus (H. Bolus) Harms, Maesa lanceolata Forssk, Elaeodendron croceum (Thunb.) DC, Pittosporum viridiflorum Sims, Hypericum roeperianum G.W. Schimp.ex A.Rich. Var. roeperianum, Morus mesozygia Stapf ex A.Chev., Cremaspora triflora (Thonn.) K.Schum. and Calpurnia aurea (Aiton) Benth ssp aurea were collected in the summer of 2013, from the University of Pretoria Botanical Garden, Pretoria National Botanical Garden and Lowveld National Botanical Garden in Nelspruit, Mpumalanga Province South Africa. Voucher specimens were prepared and deposited in the HGWJ Schweickerdt Herbarium of the University of Pretoria (PRU) (Table 1).
Table 1

A summary of the nine medicinal plants investigated for activity against Bacillus anthracis Sterne strain

Plant name

Family

Common name(s)

Parts used

Traditional uses

Voucher No.

Hypericum roeperianum

Hypericaceae

Large-leaved Curry Bush

Leaves

Infections [42]

PRU 120126

Cremaspora triflora.

Rubiaceae

Synonym: Cremaspora coffeoides Hemsl. (1896).

Bark, roots

Tooth ache, rheumatism, swellings, intestinal parasites diuretic

PRU 120129

Heteromorpha arborescens

Apiaceae

Parsley tree (Eng.); Wildepietersielie (Afr.)

Leaves, roots

Abdominal pains, intestinal worms, nervous and mental disorders, shortness of breath, coughs, dysentery, headaches, dysmenorrhoea, aphrodisiac, gall sickness and red water in livestock [18, 43]

PRU 120026

Pittosporum viridiflorum

Pittosporaceae

Cheesewood (E), Kasuur (A), umVusamvu (Z)

leaves, bark

Increase lactation in cows, camels, goats and sheep, tonic, infectious diseases, inflammations and chewing stick (oral hygiene), oral fungal infections in HIV positive patients [18, 44]

PRU 120025

Bolusanthus speciosus

Fabaceae

Tree wisteria (English); Vanwykshout (Afrikaans); Mogaba (Northern Sotho); Motsokophala (Tswana); Mukambana (Venda), umHolo (Zulu)

bark

Abdominal cramps, vomiting, tuberculosis, venereal diseases, anti-termite [45]

PRU 120027

Calpurnia aurea

Fabaceae

Common Calpurnia, Calpurnia, Wild Geelkeurboom, Geelkeur (Afr.)

leaves, roots, seeds

Malaria, wound healing, stomach ache, headaches, eye infections, rheumatism, diarrhoea, leishmaniasis, taeniasis, trachoma, allergic rashes caused by caterpillar, elephantiasis, swellings, fungal skin diseases, excessive menstrual flow, amoebiasis, syphilis, giardiasis, rabies, diabetes, abscess, hypertension, maggots in wounds, control of ticks, lice and mites in chickens, mastitis in cows, other gastrointestinal tract infections in livestock [38, 46]

PRU 120024

Maesa lanceolata

Maesaceae

False assegai ( Eng. ); Valsassegaai (Afr.)

Leaves, roots, fruits

Malaria, dysentery, diarrhoea, dermatosis, hypertension, sore throat, hepatitis, cholera, taeniasis, rheumatic arthritis, pimples, flu, syphilis, gonorrhoea, stomach ache, appetizer [33, 47].

PRU 120125

Elaeodendron croceum

Celastraceae

Saffron; saffron wood, forest saffron (Eng.); saffraan, bossafraan (Afr.)

Leaves, bark, roots

Cleaning of the digestive tract, chest congestion [34, 35].

PRU 120127

Morus mesozygia

Moraceae

Black mulberry or African mulberry

Leaves, bark, roots

Arthritis, debility, malnutrition, gastroenteritis, rheumatism, venereal diseases, wound infections, dermatitis, syphilis, malaria, fever, pain, depression, peptic ulcers [48]

PRU 120128

Preparation of extracts

The finely ground dry leaf powder (3.0 g) of each plant was extracted with 30 ml acetone (technical quality; Merck chemicals (Pty) Ltd Wadeville, South Africa). Acetone is the most effective extractant for antimicrobial compounds from plants based on several parameters [22]. The suspension was shaken vigorously in 50 ml polyester centrifuge tubes and centrifuged at 4000 × g for 10 minutes (Hettich Centrifuge, Rotofix 32A, Labotec, Johannesburg, South Africa). The supernatants were decanted into preweighed glass vials after filtering with Whatman No. 1 filter paper and concentrated to dryness under a stream of cold air. The dried extracts were made up to a concentration of 10 mg/ml (stock solution) in acetone to be used in subsequent assays and stored at 5 °C in tightly stoppered glass tubes.

Test organism

Bacillus anthracis Sterne strain cultures used to determine minimum inhibitory concentration (MIC) were obtained from the Department of Veterinary and Tropical Diseases, Faculty of Veterinary Science, University of Pretoria. The bacterial cultures were maintained on Müller-Hinton agar (Merck, South Africa) at 4 °C and incubated in Müller- Hinton broth at 37 °C prior to the determination of MICs.

Antibacterial screening

The microplate serial dilution method of Eloff [23] using p- iodonitrotetrazolium violet as growth indicator was used to determine the antibacterial activity of the extracts. This method allows the calculation of minimal inhibitory concentration (MIC) values for active plant extracts against microbes. The experiment was performed in triplicate and repeated thrice to confirm activities.

Freshly inoculated bacterial culture of Bacillus anthracis Sterne strain in Müller Hinton broth were incubated overnight at 37 °C. The culture was adjusted to a McFarlane standard 1 which is equivalent to 3 × 108 colony forming units/ml. to use as inoculum, A two-fold serial dilution of plant extract (100 μl) was prepared in 96-well microtitre plates, and 100 μl of the inoculum were added to each well providing a 50 % inoculum. The presence of bacterial growth was detected by adding to each well 40 μl of 0.2 mg/ml INT (ρ-iodonotrotetrazolium violet, Sigma South Africa). Microplates were examined after 30-120 minutes incubation. Bacterial growth was indicated by a red colour change caused when INT is reduced to formazan. The lowest concentration at which a decrease in the red colour is apparent compared to the next dilution was taken as the MIC value. Gentamicin was included as positive standard in the assay, and acetone was included as a solvent control. To compare the activity of different plant extracts, the total activity in ml/g was calculated by dividing the total mass in mg extracted from 1 g of dried plant material by the MIC in mg/ml [24]. This provides the volume to which the extract from 1 g of plant material can be diluted and still inhibited the growth of the microbe. To isolate new promising compounds from plants the MIC is important, but to consider the use of an extract not only the MIC but also the quantity extracted by the solvent i.e. total activity is important.

Cytotoxic activity

The cytotoxicity of the acetone extracts against Vero monkey kidney cells was determined by using the 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay as previously described by Mosmann [25] with slight modifications. Cells were seeded at a density of 1 × 105 cells/ml (100 μl) in 96-well microtitre plates and incubated at 37 °C and 5 % CO2 in a humidified environment. After 24 hours incubation, 100 μl each of differing extract concentrations were added to the wells containing cells. Doxorubicin was used as a positive control. A suitable blank control with equivalent concentrations of acetone was also included and the plates were incubated for 48 h in a CO2 incubator. Thereafter, the medium in each well was aspirated from the cells, cells were washed with PBS, and finally 200 μl fresh medium was added to each well. Thirty microlitre of MTT (5 mg/ml in PBS) was added to each well and the plates were incubated at 37 °C for 4 h. The medium was aspirated from the wells and DMSO was added to solubilise the formed formazan crystals. The absorbance was measured using a BioTek Synergy microplate reader at 570 nm. The percentage of cell growth inhibition was calculated based on a comparison with untreated cells. The selectivity index values were calculated by dividing cytotoxicity LC50 values by the MIC values in the same units (mg/ml). The result provides an indication of the safety to toxicity ratio.

Statistical analysis

Experimental data were analysed using Microsoft Excel Version 2010. The mean values were calculated and reported as the mean ± standard deviation (SD).

Results and discussion

Extract yield and total antibacterial activity

Three reasons have been outlined as the basis for screening medicinal plants: (1) finding new phytocompounds for possible drug development (2), verifying claims of both ethnomedicinal and ethnoveterinary applications by traditional users, and (3) to develop phytomedicines for use as herbal medicines [26]. Even if results obtained from extract evaluation are expressed in quantitative terms, it is often difficult to compare different plants with the outcomes obtained [26]. The calculation of total activity (TA) of plant extracts in antimicrobial assays provide additional confirmation of their potential use. Total activity provides the volume to which active constituents in plant material can be diluted and still inhibit the growth of the tested microorganism, expressed in millilitre per gram [24]. Combined with bioautography it also indicates the quantity and quality of active constituents present in the plant extract [27]. The total antibacterial activity of the acetone leaf extracts ranged from 92 to a surprising 5562 ml/g. Maesa lanceolata and Hypericum roeperianum had the highest total activity, with values at 5562 and 2999 ml/g respectively. The high activities observed resulted from excellent MIC values, 0.02 and 0.04 mg/ml and good extraction yields at approximately 12 and 11.12 % respectively (Table 2). The low MIC value of an extract may not always mean that it is the best extract or the best fraction for further investigation. Although, all the plant extracts tested against B. anthracis had promising activity (Table 2), their low extract yield affected the total activity values when compared to Maesa lanceolata and Hypericum roeperianum. For example, Morus mesozygia, Bolusanthus speciosus, and Pittosporum viridiflorum had a lower total activity due to low extraction yield.The very low total activity of Calpurnia aurea can be ascribed to the high MIC value and low percentage extract yield. The higher the total activity, the greater is the potential for application of the specific plant extract [24]. The concept of total activity is also useful when isolating bioactive compounds to determine if there is a loss of activity and if synergism may be involved [26].
Table 2

The quantity extracted from 1 gram of dry plant material, MIC values, total activity, cytotoxicity and selectivity index (SI)

Plant names

Quantity extracted per 1 gram (mg/g)

Mean MIC (mg/ml)

Total Activity (ml/g)

Cytotoxicity (μg/ml)

SI

Hypericum roeperianum

119.97

0.04

2999

66.2 ± 0.02

1.66

Cremaspora triflora

20.17

0.16

126

57.4 ± 2.94

0.36

Heteromorpha arborescens

26.03

0.16

163

81.0 ± 7.6

0.51

Pittosporum viridiflorum

27.17

0.08

340

54.6 ± 14.3

0.68

Bolusanthus speciosus

23.03

0.04

576

52.8 ± 3.92

1.32

Calpurnia aurea

28.63

0.31

92

13.6 ± 2.26

0.04

Maesa lanceolata

111.23

0.02

5562

2.38 ± 0.25

0.12

Elaeodendron croceum

89.97

0.31

290

5.2 ± 0.24

0.02

Morus mesozygia

18.47

0.04

462

40.7 ± 1.54

1.02

Gentamicin

ND

0.0002

NA

NA

ND

Doxorubicin

NA

NA

NA

8.3 ± 1.76

ND

NA Not applicable, MIC Minimum inhibitory concentration. The standard deviation for the MICs (9 determinations) were 0.00

Minimum inhibitory concentration

The mean MIC values of the extracts ranged from 0.02 to 0.31 mg/ml (Table 2). Amongst the selected extracts, Pittosporum viridiflorum, Bolusanthus speciosus, Hypericum roeperianum, Morus mesozygia and Maesa lanceolata had good activity (Table 2). Pauw and Eloff [21] judged that only MIC values ≤ 0.1 mg/ml should be considered as good antimicrobial activity. Nonetheless, the same authors while screening 714 acetone leaf extracts of 537 different tree species included MIC values ≤ 0.16 mg/ml as relevant because they determined activity at 0.08 and 0.16 mg/ml and not at 0.1 mg/ml. This inclusions was made in order to facilitate their statistical analyses, implying that such extracts also have the potential for further investigation. Consequently, Cremaspora triflora and Heteromorpha arborescens (MIC values 0.16 mg/ml) had potentially interesting activities against B. anthracis. The traditional uses of the plants are shown in Table 1.

There are reports of other crude plant extracts active against standard B. anthracis strains and their minimum inhibitory concentrations (MIC) values were determined. MICs were also determined for ethanolic extracts of the aerial parts of Cissampelos mucronata (0.195 mg/ml), aqueous root extracts of Tephrosia villosa (0.781 mg/ml) [28], aqueous extracts of Combretum adenogonium leaves(0.31 mg/ml) and the stem bark and root (2.5 mg/ml) [29]. Minimum bactericidal concentration (MBC) of Teucrium polium against B. anthracis is 10 mg/ml [20]. With the exception of Elaeodendron croceum and Calpurnia aurea all the results found in this study were between ten and 125 times higher than values previously reported. This may be due to the extractant, plant or bioassay that was used [22].

Cytotoxicity

Despite a common belief that plant extracts and phytoconstituent are safe, many plant metabolites are very toxic [30]. In vitro toxicity screening is a compulsory aspect of the pilot safety assessment of plant extracts and compounds before further development and commercialisation [31]. The active ingredients of crude extracts are chemicals that may be similar to those in purified medications, and may have the same potential to cause serious adverse effects [30]. The in vitro cytotoxicity of the crude acetone leaf extracts of the nine selected plants are presented in Table 2. The extracts had varying degrees of toxicity on the Vero cell lines, with LC50 values ranging from 2.38 ± 0.25 to 81.0 ± 7.6 μg/ml. In classifying the safety of plant extracts, LC50 values > 20 μg/ml were considered non-toxic [32]. Hence, Calpurnia aurea, Elaeodendron croceum and Maesa lanceolata had a high cytotoxicity in this study. Previous studies on these plant species revealed their toxicities to different cell lines [3336]. Cytotoxicity of natural and semi-synthetic analogs of alkylated benzoquinones isolated from the leaves and fruits of Maesa lanceolata against Human leukaemia (HL-60) cell lines have been reported, with LC50 ranging from 0.23-4.5 μg/ml [36]. The stem barks of Calpurnia aurea have previously been reported as poisonous to fish [37]. Similarly, Zorloni et al. [38] reported that both acetone and aqueous leaf extracts of Calpurnia aurea on ticks either immobilised or killed the arachnids. Our results agree with those of Yelani et al. [35], regarding the cytotoxicity of Elaeodendron croceum on Vero cells. They isolated five toxic triterpenoids 20-hydroxy-20-epi-tingenone, tingenone, tingenine B, 11-hydroxy-amyrin and naringenin from Elaeodendron croceum leaves.

Hypericum roeperianum had the highest selectivity index of 1.66. The higher the value of the selectivity index the safer the extract is (Table 2). This value shows the ratio of efficacy to toxicity helps to eliminate activity that may possibly be due to a general metabolic toxin [39]. The selectivity index differentiates between activity that is caused by general toxicity and one that is selectively toxic to the microorganism [39]. Although Maesa lanceolata had excellent MIC value and total antibacterial activity against B. anthracis, it was not suitable for further investigation because of its toxicity and low selectivity index (Table 2).

Conclusions

In a review of anthrax in animals, Beyer and Turnbull [3] recounted different incidences where millions of livestock died from anthrax in Russia, Iran and South Africa. Regular infections of livestock with B. anthracis present a consequent risk to public health [8]. Sporadic outbreaks of anthrax occur frequently in Africa [1, 11], due to constraints of treatment, prevention and control measures. The expense of decontaminating polluted anthrax sites, and unavailability of approved disinfectants is high [2, 11]. In the face of these challenges, indigenous medicinal plant extracts may serve as potential alternatives to chemicals as disinfectants or decontaminants, especially in situations where such chemicals are not accessible to the farmers. In an experiment to demonstrate the killing potency of garlic, a 1 % garlic powder in water killed 100 % Bacillus anthracis (1.0 × 107 cfu/ml) after three hours of exposure [40]. Eucalyptus leaf oil has bacteriostatic effect against B. anthracis [40]. There are claims that Dicerocaryum eriocarpum soaked in water can be used to disinfect the hands of individuals who touched the carcass of an animal that died from anthrax [41]. Hence, we propose that Maesa lanceolata and Hypericum roeperianum that had high total activities can be investigated as decontaminants or disinfectants, and active principles responsible for the mode of action should be isolated and characterized. Maesa lanceolata extracts had a high cytotoxicity and should not be used to protect animals against anthrax. Hypericum roeperianum extracts would be a good choice to use on animals due to its high total activity and high selectivity index.

The crude acetone extracts of the tested plant species revealed promising antibacterial activity against B. anthracis. Investigating the potential of these plant extracts to protect humans or animals against anthrax may lead to the development of new therapeutic agents. Since there are very few reports of in vivo studies of plant extracts against anthrax, such tests could be carried out using laboratory animal models. It would also be very interesting to determine the mechanism of activity.

Abbreviations

INT: 

p-iodonitrotetrazolium violet

LC50

Lethal concentration killing 50 % of the cells

MIC: 

Minimum Inhibitory Concentration

MTT: 

3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide

SD: 

Standard Deviation

SI: 

Selectivity Index

TA: 

Total Activity

Declarations

Acknowledgement

The National Research Foundation of South Africa (Eloff 95991) and the University of Pretoria provided financial support. The curators of the Pretoria National Botanical Gardens, the Lowveld National Botanical Gardens in Nelspruit and the University of Pretoria Botanical Garden allowed us to collect plant material. The Department of Veterinary and Tropical Diseases (DVTD), University of Pretoria, provided Bacillus anthracis Sterne Vaccine strain and Dr Henriette van Heerden and Miss Ayesha Hassim from the Department of Veterinary Tropical Diseases gave us the idea to investigate the activity of plant extracts on Anthrax.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Phytomedicine Programme, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria
(2)
Present address: Drug Development Section, Biochemistry Division, National Veterinary Research Institute
(3)
Present address: Department of Biochemistry, Faculty of Science, University of Dschang

References

  1. World Health Organization, World Organisation for Animal Health, Food and Agriculture Organization of the United Nations. Anthrax in humans and animals. 2008. p. 219.Google Scholar
  2. Himsworth CG. The danger of lime use in agricultual anthrax disinfection procedures:The potential role of calcium in the preservation of anthrax spores. Can Vet J. 2008;49:1208–10.PubMedPubMed CentralGoogle Scholar
  3. Beyer W, Turnbull PCB. Anthrax in animals. Mol Aspects Med. 2009;30:481–9.PubMedView ArticleGoogle Scholar
  4. Beierlein JM, Anderson AC. New Developments in Vaccines, Inhibitors of Anthrax Toxins, and Antibiotic Therapeutics for Bacillus anthracis. Curr Med Chem. 2011;18:5083–94.PubMedPubMed CentralView ArticleGoogle Scholar
  5. Spencer RC. Bacillus anthracis. J Clin Pathol. 2003;56:182–7.PubMedPubMed CentralView ArticleGoogle Scholar
  6. Welkos SL, Friedlander AM. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb Pathog. 1988;4:53–69.PubMedView ArticleGoogle Scholar
  7. Anthrax Sterne strain (34 F2 ) of Bacillus anthracis. [http://www.cdc.gov/nczved/divisions/dfbmd/diseases/anthrax_sterne/]
  8. Sharp RJ, Roberts AG. Anthrax: the challenges for decontamination. J Chem Technol Biotechnol. 2006;81:1612–25.View ArticleGoogle Scholar
  9. Ndumnego OC, Crafford J, Beyer W, Heerden HVH. Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats. BMC Vet Res. 2013;9:265.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Smith KL, Devos V, Bryden H, Price LB, Keim P, Vos VDE. Bacillus anthracis Diversity in Kruger National Park. J Clin Microbiol. 2000;38:3780–4.PubMedPubMed CentralGoogle Scholar
  11. Chikerema SM, Pfukenyi DM, Hang’ombe BM, L’Abee-Lund TM, Matope G. Isolation of Bacillus anthracis from soil in selected high-risk areas of Zimbabwe. J Appl Microbiol. 2012;113:1389–95.PubMedView ArticleGoogle Scholar
  12. Athamna A, Athamna M, Abu-Rashed N, Medlej B, Bast DJ, Rubinstein E. Selection of Bacillus anthracis isolates resistant to antibiotics. J Antimicrob Chemother. 2004;54:424–8.PubMedView ArticleGoogle Scholar
  13. Brook I, Elliott TB, Pryor HI, Sautter TE, Gnade BT, Thakar JH, et al. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int J Antimicrob Agents. 2001;18:559–62.PubMedView ArticleGoogle Scholar
  14. Choe CH, Bouhaouala SS, Brook I, Elliott TB, Knudson GB. In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis sterne [2]. Antimicrob Agents Chemother. 2000;44:1766.PubMedPubMed CentralView ArticleGoogle Scholar
  15. Bussmann R, Swartzinsky P, Worede A, Evangelista P. Plant use in Odo-Bulu and Demaro, Bale region, Ethiopia. J Ethnobiol Ethnomed. 2011;7:1–21.View ArticleGoogle Scholar
  16. Dold A, Cocks M. The trade in medicinal plants in the Eastern Cape Province, South Africa. S Afr J Sci. 2002;98(December):589–97.Google Scholar
  17. Van der Merwe D, Swan GE, Botha CJ. Use of ethnoveterinary medicinal plants in cattle by Setswana-speaking people in the Madikwe area of the North West Province of South Africa. J S Afr Vet Assoc. 2001;72:189–96.PubMedGoogle Scholar
  18. McGaw LJ, Eloff JN. Ethnoveterinary use of southern African plants and scientific evaluation of their medicinal properties. J Ethnopharmacol. 2008;119:559–74.PubMedView ArticleGoogle Scholar
  19. Moshi MJ, Otieno DF, Mbabazi PK, Weisheit A. The ethnomedicine of the Haya people of Bugabo ward, Kagera Region, north western Tanzania. J Ethnobiol Ethnomed. 2009;5:24.PubMedPubMed CentralView ArticleGoogle Scholar
  20. Darabpour E, Motamedi H, Nejad SMS. Antimicrobial properties of Teucrium polium against some clinical pathogens. Asian Pac J Trop Med. 2010;3:124–7.View ArticleGoogle Scholar
  21. Pauw E, Eloff JN. Which tree orders in southern Africa have the highest antimicrobial activity and selectivity against bacterial and fungal pathogens of animals? BMC Complement Altern Med. 2014;14:317.PubMedPubMed CentralView ArticleGoogle Scholar
  22. Eloff JN. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol. 1998;60:1–8.PubMedView ArticleGoogle Scholar
  23. Eloff JN. A Sensitive and Quick Microplate Method to Determine the Minimal Inhibitory Concentration of Plant Extracts for Bacteria. Planta Med. 1998;64:711–3.PubMedView ArticleGoogle Scholar
  24. Eloff JN. On expressing the antibacterial activity of plant extracts - a small first step in applying scientific knowledge to rural primary health care. S Afr J Sci. 2000;96:116–8.Google Scholar
  25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.PubMedView ArticleGoogle Scholar
  26. Eloff JN. Quantification the bioactivity of plant extracts during screening and bioassay guided fractionation. Phytomedicine. 2004;11:370–1.PubMedView ArticleGoogle Scholar
  27. Masoko P, Picard J, Eloff JN. Antifungal activities of six South African Terminalia species (Combretaceae). J Ethnopharmacol. 2005;99:301–8.PubMedView ArticleGoogle Scholar
  28. Nondo RSO, Mbwambo ZH, Kidukuli AW, Innocent EM, Mihale MJ, Erasto P, et al. Larvicidal, antimicrobial and brine shrimp activities of extracts from Cissampelos mucronata and Tephrosia villosa from coast region, Tanzania. BMC Complement Altern Med. 2011;11:33.PubMedView ArticleGoogle Scholar
  29. Mushi NF, Mbwambo ZH, Innocent E, Tewtrakul S. Antibacterial, anti-HIV-1 protease and cytotoxic activities of aqueous ethanolic extracts from Combretum adenogonium Steud. Ex A. Rich (Combretaceae). BMC Complement Altern Med. 2012;12:163.PubMedPubMed CentralView ArticleGoogle Scholar
  30. Mendoca-Filho RR. Bioactive Phytocompounds: New Approaches in Phytosciences. 1st ed. Weinheim: Wiley-VCH Verlag GmbH & Co KGaA; 2006.Google Scholar
  31. Eloff JN, McGaw LJ. Plant Extracts Used to Treat Bacterial, Fungal and Parasitic Infections. In: Modern Phytomedicine- Turn Medicinal Plants into Drugs. 1st ed. Weinheim: Wiley-VCH Verlag GmbH & Co KGaA; 2006.Google Scholar
  32. Zirihi GN, Mambu L, Guédé-Guina F, Bodo B, Grellier P. In vitro antiplasmodial activity and cytotoxicity of 33 West African plants used for treatment of malaria. J Ethnopharmacol. 2005;98:281–5.PubMedView ArticleGoogle Scholar
  33. Sindambiwe JB, Calomme M, Geerts S, Pieters L, Vlietinck AJ, Vanden Berghe DA. Evaluation of biological activities of triterpenoid saponins from Maesa lanceolata. J Nat Prod. 1998;61:585–90.PubMedView ArticleGoogle Scholar
  34. Prinsloo G, Meyer JJM, Hussein AA, Munoz E, Sanchez R. A cardiac glucoside with in vitro anti-HIV activity isolated from Elaeodendron croceum. Nat Prod Res. 2010;24:1743–6.PubMedView ArticleGoogle Scholar
  35. Yelani T, Hussein AA, Meyer JJM. Isolation and identification of poisonous triterpenoids from Elaeodendron croceum. Nat Prod Res. 2010;24:1418–25.PubMedView ArticleGoogle Scholar
  36. Muhammad I, Takamatsu S, Walker LA, Mossa JS, Fong HHS, El-Feraly FS. Cytotoxic and antioxidant activities of alkylated benzoquinones from Maesa lanceolata. Phyther Res. 2003;17:887–91.View ArticleGoogle Scholar
  37. Neuwinger HD. Plants used for poison fishing in tropical Africa. Toxicon. 2004;44:417–30.PubMedView ArticleGoogle Scholar
  38. Zorloni A, Penzhorn BL, Eloff JN. Extracts of Calpurnia aurea leaves from southern Ethiopia attract and immobilise or kill ticks. Vet Parasitol. 2010;168:160–4.PubMedView ArticleGoogle Scholar
  39. Adamu M, Naidoo V, Eloff JN. Efficacy and toxicity of thirteen plant leaf acetone extracts used in ethnoveterinary medicine in South Africa on egg hatching and larval development of Haemonchus contortus. BMC Vet Res. 2013;9:38.PubMedPubMed CentralView ArticleGoogle Scholar
  40. Mesfin T, Obsa T. Ethiopian traditional veterinary practices and their possible contribution to animal production and management. Rev Sci Tech. 1994;13:417–24.PubMedGoogle Scholar
  41. Beinart W, Brown K. African Local Knowledge and Livestock. Diseases and Treatments in South Africa. 1st ed. Suffolk: Boydell and Brewer Ltd.; 2013.Google Scholar
  42. Smith K. Structure and synthesis of phloroglucinol derivatives from Hypericum roeperianum. MSc Thesis. University of KwaZulu-Natal, South Africa; 2010Google Scholar
  43. Nkomo M, Kambizi L. Antimicrobial activity of Gunnera perpensa and Heteromorpha arborescens var. abyssinica. J Med Plants Res. 2009;3:1051–1055.Google Scholar
  44. Sher H, Alyemeni MN. Pharmaceutically important plants used in traditional system of arab medicine for the treatment of livestock ailments in the Kingdom of Saudi Arabia. African J Biotechnol. 2011;10:9153–9.Google Scholar
  45. Mulaudzi RB, Ndhlala AR, Kulkarni MG, Finnie JF, Van Staden J. Anti-inflammatory and mutagenic evaluation of medicinal plants used by Venda people against venereal and related diseases. J Ethnopharmacol. 2013;146:173–9.PubMedView ArticleGoogle Scholar
  46. Kalayou S, Haileselassie M, Gebre-egziabher G, Tiku’e T, Sahle S, Taddele H, et al. In-vitro antimicrobial activity screening of some ethnoveterinary medicinal plants traditionally used against mastitis, wound and gastrointestinal tract complication in Tigray Region, Ethiopia. Asian Pac J Trop Biomed. 2012;2:516–22.PubMedPubMed CentralView ArticleGoogle Scholar
  47. Manguro LOA, Midiwo JO, Tietze LF, Hao P. Triterpene saponins of Maesa lanceolata leaves. Arkivoc. 2011;2011:172–98.Google Scholar
  48. Zelefack F, Guilet D, Valentin A, Soh RC, Kom B, Chevalley S, et al. Antiplasmodial and cytotoxic activities of flavonoids and arylbenzofuran derivatives from Morus mesozygia. Greener J Biol Sci. 2012;2:20–4.View ArticleGoogle Scholar

Copyright

© Elisha et al. 2016

Advertisement